{"nct_id":"NCT04126213","title":"Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2019-11-05","start_date_type":"ACTUAL","primary_completion_date":"2020-07-23","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}